All major research ethics policies assert that the ethical review of clinical trial protocols should include a systematic assessment of risks and benefits. But despite this policy, protocols do not typically contain explicit probability statements about the likely risks or benefits involved in the proposed research. In this essay, I articulate a range of ethical and epistemic advantages that explicit forecasting would offer to the health research enterprise. I then consider how some particular confidence levels may come into conflict with the principles of ethical research.
- Research Ethics
- Philosophy of Medicine
- Clinical trials
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Should desperate volunteers be included in randomised controlled trials?
- Learning health systems, clinical equipoise and the ethics of response adaptive randomisation
- Position statement on ethics, equipoise and research on charged particle radiation therapy
- Ethical problems of evaluating a new treatment for melioidosis
- Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
- Trust based obligations of the state and physician-researchers to patient-subjects
- Contextual equipoise: a novel concept to inform ethical implications for implementation research in low-income and middle-income countries
- Delaying and withholding interventions: ethics and the stepped wedge trial
- Using qualitative methods in pilot and feasibility trials to inform recruitment and retention processes in full-scale randomised trials: a qualitative evidence synthesis
- A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial